Small-cell lung cancer (SCLC) is an aggressive cancer with limited treatment options. Nearly all cases show deregulation in cell cycle progression, a therapeutic vulnerability that can be exploited.
9don MSN
TBRG4 identified as marker of poor survival and driver of tumor progression in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...
A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
News-Medical.Net on MSN
Thiostrepton suppresses rhabdomyosarcoma progression by targeting the PI3K–AKT pathway
Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas.
MedPage Today on MSN
Checkpoint Blockade Finally Breaks Through in Ovarian Cancer
BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...
Here are the top medical news for the day:mRNA COVID vaccines may improve survival rates in cancer patients, Study shows ...
News-Medical.Net on MSN
Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug
Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas.
As the Israeli Hamas ceasefire appears to be holding, Palestinians are grappling with what comes next in their quest for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback